Fibromyalgia patients face a frustrating reality: conventional medications often fall short of providing meaningful relief from the chronic widespread pain that defines this condition. For the estimated 2-4% of adults living with fibromyalgia syndrome, finding effective non-drug treatments represents a critical pathway toward improved quality of life and functional capacity.
This comprehensive umbrella review analyzed nine systematic reviews examining transcutaneous electrical nerve stimulation (TENS) effectiveness for fibromyalgia management. The analysis reveals that TENS delivers modest but measurable short-term pain reduction, with optimal results occurring when higher-intensity protocols are administered across 10 or more treatment sessions. However, improvements in functional capacity and psychosocial measures remained inconsistent across studies, suggesting pain relief may not automatically translate to broader life improvements.
The findings align with growing recognition that fibromyalgia requires multimodal treatment approaches rather than single interventions. While TENS represents a low-risk, accessible option that some patients find beneficial, the evidence suggests it functions best as one component within comprehensive pain management strategies. The research landscape reveals significant protocol variations across studies, making direct comparisons challenging and highlighting the need for standardized treatment parameters. For clinicians and patients, these results support cautious optimism about TENS utility while emphasizing realistic expectations about outcomes and duration of benefits.